"Proportional Hazards Models" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.
Descriptor ID |
D016016
|
MeSH Number(s) |
E05.318.740.500.700 E05.318.740.600.700 E05.318.740.750.725 E05.318.740.998.825 E05.599.835.900 N05.715.360.750.530.650 N05.715.360.750.625.650 N05.715.360.750.695.650 N05.715.360.750.795.825 N06.850.520.830.500.700 N06.850.520.830.600.700 N06.850.520.830.750.725
|
Concept/Terms |
Proportional Hazards Models- Proportional Hazards Models
- Proportional Hazard Models
- Hazard Model, Proportional
- Hazard Models, Proportional
- Model, Proportional Hazard
- Models, Proportional Hazard
- Proportional Hazard Model
- Models, Proportional Hazards
- Hazards Model, Proportional
- Hazards Models, Proportional
- Model, Proportional Hazards
- Proportional Hazards Model
Hazards Models- Hazards Models
- Hazards Model
- Model, Hazards
- Models, Hazards
- Hazard Models
- Hazard Model
- Model, Hazard
- Models, Hazard
|
Below are MeSH descriptors whose meaning is more general than "Proportional Hazards Models".
Below are MeSH descriptors whose meaning is more specific than "Proportional Hazards Models".
This graph shows the total number of publications written about "Proportional Hazards Models" by people in this website by year, and whether "Proportional Hazards Models" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
2011 | 0 | 5 | 5 |
2012 | 0 | 1 | 1 |
2013 | 0 | 6 | 6 |
2014 | 0 | 4 | 4 |
2015 | 0 | 1 | 1 |
2016 | 0 | 3 | 3 |
2017 | 0 | 3 | 3 |
2018 | 0 | 3 | 3 |
2019 | 0 | 2 | 2 |
2020 | 0 | 1 | 1 |
2021 | 0 | 3 | 3 |
2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proportional Hazards Models" by people in Profiles.
-
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. Cancer Med. 2023 08; 12(15):16142-16162.
-
Investigating non-inferiority or equivalence in time-to-event data under non-proportional hazards. Lifetime Data Anal. 2023 07; 29(3):483-507.
-
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis. Eur J Cancer. 2021 09; 154:128-137.
-
Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies. JAMA Cardiol. 2021 05 01; 6(5):587-592.
-
Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy. J Natl Cancer Inst. 2021 04 06; 113(4):443-452.
-
Risk prediction for coronary heart disease by a genetic risk score - results from the Heinz Nixdorf Recall study. BMC Med Genet. 2020 09 10; 21(1):178.
-
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(=3) chemotherapy - The GCIG symptom benefit study (SBS). Gynecol Oncol. 2020 01; 156(1):45-53.
-
Higher circulating omentin is associated with increased risk of primary cardiovascular events in individuals with diabetes. Diabetologia. 2020 02; 63(2):410-418.
-
The association between birth order and childhood leukemia may be modified by paternal age and birth weight. Pooled results from the International Childhood Cancer Cohort Consortium (I4C). Int J Cancer. 2019 01 01; 144(1):26-33.
-
Filtration based assessment of CTCs and CellSearch? based assessment are both powerful predictors of prognosis for metastatic breast cancer patients. BMC Cancer. 2018 02 20; 18(1):204.